Renin–Angiotensin–Aldosterone System inhibitors in patients with Covid-19

Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J.V. , Pfeffer, M. A. and Solomon, S. D. (2020) Renin–Angiotensin–Aldosterone System inhibitors in patients with Covid-19. New England Journal of Medicine, 382(17), pp. 1653-1659. (doi: 10.1056/nejmsr2005760) (PMID:32227760)

[img] Text
213578.pdf - Published Version

690kB

Abstract

No abstract available.

Item Type:Articles
Keywords:General medicine.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J.V., Pfeffer, M. A., and Solomon, S. D.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:New England Journal of Medicine
Publisher:Massachusetts Medical Society
ISSN:0028-4793
ISSN (Online):1533-4406
Copyright Holders:Copyright © 2020 Massachusetts Medical Society
First Published:First published in New England Journal of Medicine 382(17):1653-1659
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record